141 related articles for article (PubMed ID: 22711886)
1. TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice.
Pérez-Chacón G; Llobet D; Pardo C; Pindado J; Choi Y; Reed JC; Zapata JM
J Immunol; 2012 Jul; 189(2):1053-61. PubMed ID: 22711886
[TBL] [Abstract][Full Text] [Related]
2. The
Perez-Chacon G; Zapata JM
Front Immunol; 2021; 12():627602. PubMed ID: 33912159
[TBL] [Abstract][Full Text] [Related]
3. TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice.
Zapata JM; Krajewska M; Morse HC; Choi Y; Reed JC
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16600-5. PubMed ID: 15545599
[TBL] [Abstract][Full Text] [Related]
4. TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs.
Vashisht M; Ge H; John J; McKelvey HA; Chen J; Chen Z; Wang JH
Cell Death Dis; 2023 Sep; 14(9):599. PubMed ID: 37679334
[TBL] [Abstract][Full Text] [Related]
5. TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.
Woolaver RA; Wang X; Dollin Y; Xie P; Wang JH; Chen Z
J Immunol; 2018 Dec; 201(11):3421-3430. PubMed ID: 30341187
[TBL] [Abstract][Full Text] [Related]
6. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation.
Munroe ME; Bishop GA
J Biol Chem; 2004 Dec; 279(51):53222-31. PubMed ID: 15485859
[TBL] [Abstract][Full Text] [Related]
8. TRAF2 phosphorylation promotes NF-κB-dependent gene expression and inhibits oxidative stress-induced cell death.
Zhang L; Blackwell K; Altaeva A; Shi Z; Habelhah H
Mol Biol Cell; 2011 Jan; 22(1):128-40. PubMed ID: 21119000
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.
Rowland SL; Tremblay MM; Ellison JM; Stunz LL; Bishop GA; Hostager BS
J Immunol; 2007 Oct; 179(7):4645-53. PubMed ID: 17878362
[TBL] [Abstract][Full Text] [Related]
10. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
11. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
[TBL] [Abstract][Full Text] [Related]
12. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
Graham JP; Moore CR; Bishop GA
J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
[TBL] [Abstract][Full Text] [Related]
13. Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma.
Hui D; Satkunam N; Al Kaptan M; Reiman T; Lai R
Mod Pathol; 2006 Sep; 19(9):1192-202. PubMed ID: 16763612
[TBL] [Abstract][Full Text] [Related]
14. Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury.
Tzeng HP; Evans S; Gao F; Chambers K; Topkara VK; Sivasubramanian N; Barger PM; Mann DL
J Am Heart Assoc; 2014 Feb; 3(1):e000662. PubMed ID: 24572254
[TBL] [Abstract][Full Text] [Related]
15. TNFR2 increases the sensitivity of ligand-induced activation of the p38 MAPK and NF-κB pathways and signals TRAF2 protein degradation in macrophages.
Ruspi G; Schmidt EM; McCann F; Feldmann M; Williams RO; Stoop AA; Dean JL
Cell Signal; 2014 Apr; 26(4):683-90. PubMed ID: 24378531
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation.
Widhopf GF; Brinson DC; Kipps TJ; Tighe H
J Immunol; 2004 Feb; 172(4):2092-9. PubMed ID: 14764674
[TBL] [Abstract][Full Text] [Related]
17. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.
Grech AP; Amesbury M; Chan T; Gardam S; Basten A; Brink R
Immunity; 2004 Nov; 21(5):629-42. PubMed ID: 15539150
[TBL] [Abstract][Full Text] [Related]
18. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.
Gardam S; Sierro F; Basten A; Mackay F; Brink R
Immunity; 2008 Mar; 28(3):391-401. PubMed ID: 18313334
[TBL] [Abstract][Full Text] [Related]
19. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
20. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
